Account
Spykar hands over media duties to Zenith
MUMBAI: Zenith has won the media duties of jeanswear brand Spykar.
The business was won as part of a competitive multi-agency pitch.
Spykar was established in 1992. It is now part of the Lord Bagri promoted Metdist Group, a global conglomerate with interests in diverse range of industries, including metals, fashion, hospitality and technology.
Zenith India Group CEO Tanmay Mohanty says, “We couldn’t be more thrilled to partner with Spykar, which is India’s own home-grown contemporary jeanswear brand and needs no introduction. Our ROI-focused approach will drive maximum business growth for Spykar, on the back of strong tech, analytics, content and consumer-centric insights. This win is testament to our scale and ability to bring in astute media strategies for powerful, integrated brand campaigns.”
Spykar CEO Sanjay Vakharia adds, “Spykar has been India’s leading denim brand for 25 years. Great product coupled with wide spread distribution has given us exemplary growth. In the last three years, our revenues have doubled. This has encouraged us to pursue aggressive growth plans and we were looking for a partner who can help us in achieving our goals. We have selected Zenith after a comprehensive pitch process. They have dived deeply into our business and impressed us with their vision and proficiency in delivering effective, data-driven, personalised plans. Lifestyle clothing is a dynamic, high-growth business and we are sure that Zenith’s strategic insights will unlock new opportunities for us. Their culture of innovation is akin to our own and we look forward to working with them.”
Spykar has denim apparel for men and women and is available pan-India across 220 standalone stores, across 140 cities and over 700 SIS (shop in shops) and 700 multi-brand outlets across 350 cities of the country. It is also available on its own e-commerce platform, apart from all online fashion portals.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
